Ask AI

Beyond the Joints: A Whole-Body Approach to Psoriatic Arthritis Care Through Integrated Obesity Management

Video
This activity is available for 1.00 CME/CE credit(s).

Released: October 16, 2026

Expiration: October 15, 2027

See Activity Collection

Better understand the bidirectional relationship between psoriatic arthritis (PsA) and obesity with this on-demand webcast, including the adverse effects of excess adiposity on inflammation, PsA disease activity and treatment response, and overall cardiometabolic risk. Then discover patient-centered communication strategies that will help you integrate comprehensive obesity care (ie, screening, pharmacotherapy, multidisciplinary management, and the latest evidence) into your PsA practice.

PsA and obesity whole person care

Pre Assessment

Assess your current knowledge and clinical approach before beginning your video.
1.

How many people with obesity do you provide care for in a typical week?

2.

For those who practice in academic or community settings, please indicate your practice setting:

3.

Do you currently prescribe GLP-1 receptor agonists and/or dual GIP/GLP-1 receptor agonists for patients with PsA and obesity?

4.

How confident are you in prescribing GLP-1 receptor agonists and/or dual GIP/GLP-1 receptor agonists for patients with PsA and obesity?

5.

Michael asks how his weight affects his PsA. Which interpretation best reflects how obesity may be contributing to Michael’s current symptoms?

6.

Michael is uncertain how talking about his weight will improve his PsA. Which approach would you use to address Michael’s uncertainties?

7.

Based on Michael’s history, what treatment would you recommend for him?